Big Pharma is living off the fat of the land
Obesity is big business in South Africa, and Big Pharma is cashing in.
Helluva Easter, that was. JD Vance killed the pope and I didn't drink enough to even get a hangover. The devil works in mysterious ways.
Anyway, that's not what I want to talk about this week. Over the interminable weekend, I frequented Durban's beachfront on several occasions for reasons which, according to my lawyer, need not be ventilated in public.
My peregrinations up and down the boulevard of broken dreams, once known as the Golden Mile, resulted in several encounters with people of a girth quite unlike anything I have ever seen.
This alarming experience was replicated in Umhlanga and Ballito.
I'm not being fattist. I've heard people say that obesity is a problem in South Africa. I disagree. It all depends on how you handle it.
Obesity only becomes a problem if it tries to sit on you. Or if you unwisely fail to step aside to let it pass unhindered.
I have never looked at a very fat person and wondered how I could make money out of them. Do you know who has, though? The pharmaceutical industry, that's who.
Like the people they're aimed at, weight-loss drugs are bigger than ever. Sales of obesity treatments are set to hit $150 billion in a few years and the traffickers are racing to get ahead in the game.
These companies are doing the Lord's work. You can help them by stuffing yourself with puddings and pies around the clock.
Thanks to drugs, Clicks' turnover has grown by 9.2% to R4.7 billion. That's the equivalent of 152 swimming pools filled with cocaine.
I'm talking about the good stuff here, not the rubbish from Hillbrow that'll give you a septum with more deviations than the road from Kokstad to Mthatha.
ALSO READ: Diabetes and kidney disease – a silent, but serious threat
To be fair, this profit has been driven by all classes of medicine. When it comes to running according to schedule, drugs beat our trains hands down.
Our pharmaceuticals range from schedule 0, which includes time-wasting nonsense like aspirin and vitamins, right up to schedule 8.
Things start getting interesting from schedule 6, so you might want to kick off there, regardless of your condition.
Most of the ailments listed in the ever-expanding Diagnostic and Statistical Manual of Mental Disorders (its sixth edition is in the works) can be treated with pills or a sharp slap across the side of the head.
If those fail, shouting 'get a grip!' has been known to work, although relapses are common.
Fat people, though. Those are the real cash cows. Who among us doesn't want to lose weight?
Could the Sudanese refugees at the back please put their hands down. I'm sure Big Pharma is working on a weight-gain pill for you as we speak.
You could hurry things along by demonstrating that you have money. You can't expect them to make drugs for people who can't afford them, can you? That would be crazy.
So, the demand for weightloss products like Ozempic has boosted Clicks pharmacy sales. And more good news is that the company is poised to get even richer given the increase in diabetes patients, many of whom would rather lose weight than die.
'In South Africa, diabetes is a massive problem,' said CEO Bertina Engelbrecht, in what could have been a brilliant pun if all diabetics were overweight.
'Globally, the demand for Ozempic and Wegovy, also a weight-loss product for diabetes patients, pumped $26 billion into maker Novo Nordisk last year,' said one news report.
ALSO READ: Beware of fake Ozempic and Mounjaro used for weight loss, Sahpra urges
Once again, let me point out that not all fat people are diabetics and not all diabetics are fat. I say this to protect myself and nobody else. There's no telling what either group is capable of if pushed too far.
Clicks, with 950 stores, opened 20 new pharmacies in the six months up to February and dozens more are planned this year.
'We have a steady pipeline of pharmacy licences which inspires confidence that we will resume our market share gain in retail pharmacy this year,' said Engelbrecht.
Or, in another universe: 'We are deeply concerned that the number of sick people in this country is spiralling but we will do our best to make them well again.'
But wait. There's even more good news for the larger person. Eli Lilly, America's pharmaceutical cephalopod with tentacles in 125 countries, has also produced an experimental pill that helps people lose weight while helping the $775 billion company get even richer at the same time.
It's a pill called orforglipron. Presumably if you can pronounce it, you can afford it.
The late-stage trial found that up to 18% of patients who necked the drug experienced nausea, up to 26% got the runs and up to 14% barfed.
This, apparently, is a brilliant result. The only way I'd risk side effects like these is if the pill also had hallucinogenic properties.
On Monday, Pfizer discontinued its experimental weight-loss pill. It has the equally mellifluous name, danuglipron.
This came after a trial patient's liver complained. I have a liver that disagrees with many things but you won't catch me discontinuing anything.
We South Africans aren't quitters, even if it kills us.
NOW READ: Sugary drinks are a killer: a 20% tax would save lives and rands in SA
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Eyewitness News
a day ago
- Eyewitness News
Africa should step up own vaccines, says cholera-hit Angola
LUANDA - Africa should step up production of its own vaccines to deal with a range of health issues, Angola, battling hundreds of cholera deaths this year, said Wednesday. "To enable a strong and sustainable response to this crisis and future crises, it is essential to put production of medicines and vaccines on our continent," Angolan President Joao Lourenco, who also heads the African Union, told a videoconference with other African leaders, his office said. "Total dependence on external imports limits our ability to respond and compromises our health sovereignty," Lourenco said during a conference which included World Health Organization (WHO) director general Tedros Adhanom Ghebreyesus. More than 90 percent of vaccines, medicines, medical tests, and other essential health supplies used in Africa are imported, according to a report by the African Centre for Disease Control and Prevention (ACDCP) published in April. Several African countries are battling cholera outbreaks with Sudan, South Sudan, Democratic Republic of Congo and Angola among the worst hit. As of 2 June, Angola had recorded more than 24,530 cases this year, with 718 deaths, according to the Angolan presidency. On 27 May, the Sudanese health ministry reported 172 deaths from the disease in a single week in the war-torn country. Africa's dependence on imported health products has proven disastrous during previous epidemics, including COVID-19, Ebola, Marburg and mpox, the ACDCP report said. That leaves the continent at the mercy of global trade tensions, geopolitical disruption and logistical delays, it said. Public health emergencies have significantly increased in Africa, rising from 152 in 2022 to 213 in 2024, the report added.
TimesLIVE
3 days ago
- TimesLIVE
Five killed in attack on UN food convoy heading to Sudan hunger hotspot, UN says
Aid has frequently come under crossfire in the two-year-old war between the Sudanese army and the paramilitary Rapid Support Forces (RSF), which has left more than half the population facing crisis levels of hunger and driven millions from their homes. In statements, the RSF and the army blamed each other for the latest attack. The RSF said the army had attacked in an air strike, while the army said the RSF had torched the truck. Reuters could not independently verify the contradictory accounts. The UN joint statement said the route of the 15-truck convoy, which travelled more than 1,800km from Port Sudan, had been shared with the parties in advance. It was negotiating access to complete the journey when it was attacked, it said. Al Koma is controlled by the RSF, and earlier this week saw a drone strike that claimed several civilian lives, according to local activists. Famine conditions have previously been reported in al-Fashir, the capital of North Darfur. The fighting and barriers to the delivery of aid put in place by the two sides have cut off supplies. The attack is the latest of several assaults on aid in recent days. It comes after the repeated shelling of UN World Food Programme premises in al-Fashir by the RSF and an attack on El Obeid hospital in North Kordofan that killed several medics late last month.
eNCA
3 days ago
- eNCA
Four million people have fled Sudan since start of war: UN
DARFUR - More than four million people have fled Sudan since the start of the conflict in 2023, the United Nations said Tuesday, calling the figure a "devastating milestone". UNHCR, the UN refugee agency, said that if the war continues, the outflow of people would threaten regional and global stability. Sudan's regular army and the paramilitary Rapid Support Forces (RSF) have been locked in a battle for power since April 2023. The war has killed tens of thousands of people and created the world's largest hunger and displacement crises. "Four million people now have fled Sudan into neighbouring countries since the start of the war, now in it's third year," UNHCR spokeswoman Eujin Byun said at a press briefing in Geneva. "It's a devastating milestone in what is the world's most damaging displacement crisis," he added. "If the conflict continues, thousands more people will continue to flee, putting regional and global stability at stake." UNHCR figures showed that 4,003,385 people had fled Sudan as refugees, asylum seekers, and returnees as of Monday. Of those, 1.5 million have fled to Egypt; more than 1.1 million to South Sudan, including nearly 800,000 returnees who had been refugees themselves in Sudan; and more than 850,000 to Chad. - Strain on neighbouring Chad - The UNHCR described a deepening humanitarian emergency in eastern Chad, where the number of Sudanese refugees has more than tripled since the war broke out. The country was already hosting more than 400,000 Sudanese refugees before the conflict began, and the figure has now surpassed 1.2 million. AFP | Joris Bolomey This is placing "unsustainable pressure on Chad's ability to respond", said Dossou Patrice Ahouansou, UNHCR's principal situation coordinator in Chad, speaking from Amdjarass in the country's east. He said there had been an influx across the border since late April following violent attacks in Sudan's North Darfur region, including assaults on displacement camps. In just over a month, 68,556 refugees have arrived in Chad's Wadi Fira and Ennedi Est provinces, with an average of 1,400 people crossing the border daily in recent days, he said. "These civilians are fleeing in terror, many under fire, navigating armed checkpoints, extortion, and tight restrictions imposed by armed groups," Ahouansou said. He said the emergency response was "dangerously underfunded", with people living in "dire" shelter conditions, and tens of thousands exposed to extreme weather, insecurity and water shortages. UNHCR said there was an "urgent need" for the international community "to acknowledge, and act to eradicate, the grave human rights abuses being endured in Sudan". "Without a significant increase in funding, life-saving assistance cannot be delivered at the scale and speed required," Ahouansou said. The war has effectively split Sudan in two, with the army holding the centre, east and north, while the paramilitaries and their allies control nearly all of Darfur and parts of the south.
